Back to Top
Omodenbamab Biosimilar - Research Grade
$710.00 - $6,900.00
Omodenbamab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
staphylococcal protein A
Concentration
5mg/ml
Isotype
IgG3 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Staphylococcal protein A is a virulence-associated surface factor and a target of interest in anti-staphylococcal research. This recombinant human IgG3 kappa antibody is an unconjugated, non-therapeutic analog of omodenbamab, generated in CHO cells against staphylococcal protein A. For research use only, it is prepared in a low-endotoxin format compatible with in vivo experimentation and manufactured in scalable milligram (mg) to gram (g) quantities for high-throughput laboratories. It serves as a defined reagent for functional binding studies, opsonization assays, and preclinical models of staphylococcal infection. Predictable performance across batches helps standardize multi-arm experimental designs.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












